New-diagnosed PCNSL Treated With Methotrexate (MTX) and Orelabrutinib-based Regimen

Clinical trial NCT06115824 · COMPLETED

Trial details

NCT number: NCT06115824
Sponsor: Huashan Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Primary Central Nervous System Lymphoma

Start date: 2023-08-10
Primary completion: 2024-01-30
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.